Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Abroad (travel likely)RecruitingPHASE1
Conditions
Open Angle Glaucoma (OAG) · NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Global Research Management, Inc., Glendale, California, United States
Mass Eye and Ear, Boston, Massachusetts, United States
Contact: Study coordinator (Joseph Rizzo, MD) · centerforclinicalresearchoperations@meei.harvard.edu · 617-573-6060Contact: Principal Investigator (Joseph Rizzo, MD)Columbia University Irving Medical Center/Edward S. Harkness Eye Institute, New York, New York, United States
Contact: Principal Investigator (Aakriti Shukla, MD, MSc)Charleston Neuroscience Institute, Charleston, South Carolina, United States
Study leads
Sharon Rosenzweig-Lipson, PhD
Study Chair
Life Biosciences Inc.